MolNFT v1 · #182328 · protein
Crystal structure of the tetramerization element of NUP358/RANBP2 (residues 805-832)
7MNK · E3 sumo-protein ligase RANBP2: “Crystal structure of the tetramerization element of NUP358/RANBP2 (residues 805-832)”. X-ray diffraction, 1 ligand (SO4). MolNFT v1 #182328 on GenesisL1: 3D structure, binding sites and pockets in…
- PDB
- 7MNK
- Type
- protein
- Length
- 120 residues
- Chains
- 4
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- E3 sumo-protein ligase RANBP2
- UniProt
- P49792
- Ligands
- SO4
Structure
x-ray diffraction · 1 distinct chain · 93% helix, 0% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A, B, C, D | E3 sumo-protein ligase RANBP2 | protein | 30 | 93% helix, 0% strand | P49792 |
Ligands and binding sites
- SO4 · Sulfate ion · ion · 5 copies · chains A, B, C, D
- EDO · 1,2-ethanediol · additive · 4 copies · chains A, D, B, C
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Interfaces
6 interfaces between chains.
- B–C · 795 Ų buried · 8 hydrogen bonds · protein-protein
- A–B · 736 Ų buried · 4 hydrogen bonds · protein-protein
- A–D · 677 Ų buried · 9 hydrogen bonds · protein-protein
- C–D · 655 Ų buried · 4 hydrogen bonds · protein-protein
- B–D · 397 Ų buried · 9 hydrogen bonds · protein-protein
Compared structures
- 7MNK · Crystal structure of the tetramerization element of NUP358/RanBP2 (residues 805-832) · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P49792
- Elsewhere: RCSB PDB 7MNK · PDBe 7MNK · UniProt P49792
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.